A comparison of matched and aggregated group outcomes data for evaluating continuing education of hematology and oncology health care professionals.

Introduction: Capturing educational outcomes from health care professionals is often challenging. Therefore, many providers utilize aggregated group data (comparing all preassessments to all postassessments) rather than matched group data (comparing pre- and postassessments only for those learners who completed both). To address the agreement between aggregate and matched outcomes, a preliminary analysis was conducted.

Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.

Recent advances in the treatment and management of haematological malignancies are due in large part to an improved understanding of the basic biology that drives tumour cell growth and survival. This improved understanding has led to the clinical study and approval of a number of different targeted agents across a number of different haematological tumours. This review of clinical data covers some of the exciting clinical advances that were reported at the recent American Society of Hematology meeting in San Diego, USA.